The Best of DDW

DDW wraps up with The Best of DDW, a recap of the best abstracts presented during the meeting. Each sponsoring society has selected discussants to review these abstracts and talk about their importance to the field.

The session will take place Tuesday, May 22, 2–4 p.m. in room 28cd. The scheduled presentations are:

2:00  Introduction

2:05  Mario Chojkier

#594 Ribavirin Dose Modification in Treatment-naïve and Previously Treated Patients who Received Telaprevir Combination Treatment: No Impact on Sustained Virologic Response in Phase 3 Studies

#593 Antisense Oligonucleotide Reduction of Mutant Alpha-1 Antitrypsin Protein for the Treatment of Alpha-1 Antitrypsin Liver Disease

#596 Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies

2:30  Juanita Merchant

#906  cKit/CD117 identifies a colonic Paneth-like cell that contributes to the stem cell niche and regulates crypt homeostasis

#258  Molecular underpinnings of highly penetrant duodenal tumors in Lrig1 null mice

#515a Dclk1 labels a multipotent and residual neural crest-derived stem cell in the gut epithelium and enteric nervous system

#517  Cell-autonomous ADAM10 signaling is essential for maintenance of long-lived multipotent intestinal stem cells

2:55  Steve Edmundowisz

#720 A Randomized Controlled Trial of Rectal Indomethacin for the Prevention of Post-ERCP Pancreatitis.

#723 EUS – guided choledochoduodenostomy versus surgical drainage in patients with unresectable distal malignant biliary obstruction: A randomized prospective trial

3:20   Mark Callery

#530 High Grade Dysplasia and Adenocarcinoma Are Frequent in Side-Branch Intraductal Papillary Mucinous Neoplasm Measuring Less Than 3cm on Endoscopic Ultrasound

3:35  Jeffrey Peters

#3372 Hiatal Hernia, Barrett’s Esophagus and Long-Term Symptom Control After Laparoscopic Fundoplication for Gastresophageal

3:50  Closing Remarks